Bringing Discoveries to Commercialization
News

Events

IU Philanthropic Venture Fund invests in ICBI companies

Friday, February 1, 2019

The Indiana Philanthropic Venture Fund (IU PhV) is on the doorstep of its one-year anniversary and, although not limited to the life sciences, it has funneled $1.6 million into the sector’s early-stage Indiana-based companies. Its visionaries designed the evergreen fund to be a “perpetual resource” and an answer for Indiana University alums who want to […]

Technology ​Seminar, February 6, 2019

Tuesday, January 29, 2019

 Meso Scale Discovery Meso Scale Discovery (MSD) is a global leader in the development, manufacture, and commercialization of innovative assays and instruments for the measurement of molecules in biological samples. MSD provides singleplex and multiplexed assays for neurodegenerative, metabolic inflammation, oncology, toxicology, cell signaling and a broad range of other disease focused biomarkers.   MSD Specialties: Protein Quantification, Ultrasensitive Immunoassay, Biomarker Testing […]

Invention to Startup forum, February 7, 2019

Thursday, January 24, 2019

Invention to Startup forum, February 7, 2019

Entrepreneur-Investor Forum detailed agenda

Friday, September 21, 2018

 

Click for more details…….

Friday, September 21, 2018

The First Academic Entrepreneur-Investor Forum Indiana Center for Biomedical Innovation (ICBI)  is hosting the “Entrepreneur-Investor Forum” on October 16th, 2018. The goal of the event is to bring together the key organizations involved in life sciences entrepreneurial ecosystem in Indianapolis and catalyze collaboration to promote commercialization of life science technologies. The event will be organized in partnership […]

HB Therapeutics Joins ICBI, Received NIH/NCI SBIR Phage I Grant

Wednesday, July 18, 2018

ICBI welcomes HB Therapeutic, Inc., which just received the NIH/NCI SBIR phase I grant of $300,000 for development of the company first small molecule degraders of small ubiquitin-like modifier-1 protein (SUMO1) as new anticancer drugs. Founded by Dr. Bellail and Dr. Hao in 2015, HB Therapeutics is a biotech company for discovery and development of […]

ICBI Company Vascugen Licenses Stem Cell Technology for Blood Vessel Regeneration, Raises $635K

Tuesday, May 1, 2018

INDIANAPOLIS, May 1, 2018 — Vascugen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University (IU) School of Medicine related to blood vessel formation from adult stem cells. The regenerative medicine company is focused on finding therapies to repair tissues damaged by reduced blood flow due to […]

ICBI Company Scioto Biosciences Closes $1.8M in Series A Financing, Receives Grants to Support Launch of New Microbiome Platform Technology

Monday, May 21, 2018

Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome platform technology. The funding represents a first-time interstate collaboration between two Indiana-based investors, BioCrossroads and Elevate Ventures, together with Ohio-based Rev1 Ventures, and follows […]

Technology Forum by Meso Scale Discovery

Tuesday, January 9, 2018

Technology seminar by Meso Scale Discovery (MSD), January 17th, 12:30-1:30 pm at the Indiana Center for Biomedical Innovation (ICBI). MSD provides singleplex and multiplexed assays for neurodegenerative, metabolic inflammation, oncology, toxicology, cell signaling and a broad range of other disease-focused biomarkers. It is also an open platform with necessary tools to help develop assays for […]

1 2 3 4